{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:56:13Z","timestamp":1769021773004,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.euros.2024.01.009","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T16:06:49Z","timestamp":1707235609000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-575X","authenticated-orcid":false,"given":"Dennie","family":"Meijer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim J.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wietse S.C.","family":"Eppinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben G.L.","family":"Vanneste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Meijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurien A.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roderick C.N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne P.","family":"Lont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves J.L.","family":"Bodar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemarijn H.","family":"Ettema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelijne C.C.","family":"de Bie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik H.K.","family":"Oudshoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakko A.","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk G.","family":"van der Poel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten L.","family":"Donswijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn W.","family":"Heymans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela E.","family":"Oprea-Lager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva E.","family":"Schaake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 N.","family":"Vis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2024.01.009_b0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-5347(05)63946-8","article-title":"Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer","volume":"169","author":"Han","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2024.01.009_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/s1677-5538.ibju.2016.0656","article-title":"Biochemical recurrence after radical prostatectomy: what does it mean?","volume":"44","author":"Tourinho-Barbosa","year":"2018","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.euros.2024.01.009_b0015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0022-5347(01)69079-7","article-title":"Cancer control with radical prostatectomy alone in 1,000 consecutive patients","volume":"167","author":"Hull","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2024.01.009_b0020","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2024.01.009_b0025","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2024.01.009_b0030","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2024.01.009_b0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II\u20142020 update: treatment of relapsing and metastatic prostate cancer","volume":"79","author":"Cornford","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.01.009_b0040","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2024.01.009_b0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.01.009_b0050","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/bju.15052","article-title":"Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (68Ga-PSMA) positron-emission\/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection","volume":"125","author":"Huits","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2024.01.009_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.euros.2021.04.002","article-title":"External validation of two nomograms developed for 68Ga-PSMA-11 applied to the prostate-specific membrane antigen tracer 18F-DCFPyl: is prediction of the optimal timing of salvage therapy feasible?","volume":"28","author":"Luiting","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2024.01.009_b0060","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/bju.13397","article-title":"68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment","volume":"117","author":"van Leeuwen","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2024.01.009_b0065","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.euo.2021.04.011","article-title":"Integrating prostate-specific antigen kinetics into contemporary predictive nomograms of salvage radiotherapy after radical prostatectomy","volume":"5","author":"Campbell","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2024.01.009_b0070","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","article-title":"Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy","volume":"25","author":"Stephenson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2024.01.009_b0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.euo.2022.01.001","article-title":"Prostate-specific membrane antigen positron emission tomography\/computed tomography is associated with improved oncological outcome in men treated with salvage radiation therapy for biochemically recurrent prostate cancer","volume":"5","author":"Meijer","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2024.01.009_b0080","unstructured":"Memorial Sloan Kettering Cancer Center. Prostate cancer nomograms: PSA doubling time. https:\/\/nomograms.mskcc.org\/prostate\/psadoublingtime.aspx"},{"key":"10.1016\/j.euros.2024.01.009_b0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13550-016-0195-6","article-title":"Automated synthesis of [18F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models","volume":"6","author":"Bouvet","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euros.2024.01.009_b0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jlcr.3430","article-title":"An improved synthesis of the radiolabeled prostate-specific membrane antigen inhibitor, [18F]DCFPyL","volume":"59","author":"Ravert","year":"2016","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.euros.2024.01.009_b0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2967\/jnumed.117.198119","article-title":"Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-Ligand PET\/CT","volume":"59","author":"Eiber","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2024.01.009_b0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2007.07.017","article-title":"Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group","volume":"84","author":"Poortmans","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.euros.2024.01.009_b0105","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.eururo.2014.11.025","article-title":"Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement","volume":"67","author":"Collins","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.01.009_b0110","unstructured":"Heymans MW. psfmi: prediction model pooling, selection and performance evaluation across multiply imputed datasets. R package version 1.0.0. https:\/\/mwheymans.github.io\/psfmi\/"},{"key":"10.1016\/j.euros.2024.01.009_b0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.radonc.2015.04.026","article-title":"Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancer","volume":"115","author":"Miyake","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.euros.2024.01.009_b0120","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.eururo.2016.03.010","article-title":"The effect of salvage radiotherapy and its timing on the health-related quality of life of prostate cancer patients","volume":"70","author":"van Stam","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.01.009_b0125","first-page":"26","article-title":"Salvage radiotherapy after radical prostatectomy: Long-term results of urinary incontinence, toxicity and treatment outcomes","volume":"11","author":"van Dessel","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.euros.2024.01.009_b0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2967\/jnumed.117.202945","article-title":"Impact of 68Ga-PSMA-11 PET\/CT on the management of prostate cancer patients with biochemical recurrence","volume":"59","author":"Calais","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2024.01.009_b0135","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1007\/s00259-021-05222-5","article-title":"Management impact of 18F-DCFPyL PET\/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study","volume":"48","author":"Meijer","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euros.2024.01.009_b0140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.euf.2020.12.009","article-title":"Update from PSMA-SRT trial NCT03582774: a randomized phase 3 imaging trial of prostate-specific membrane antigen positron emission tomography for salvage radiation therapy for prostate cancer recurrence powered for clinical outcome","volume":"7","author":"Calais","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euros.2024.01.009_b0145","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ijrobp.2022.04.048","article-title":"Metastasis-free survival and patterns of distant metastatic disease after prostate-specific membrane antigen positron emission tomography (PSMA-PET)-guided salvage radiation therapy in recurrent or persistent prostate cancer after prostatectomy","volume":"113","author":"Zamboglou","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euros.2024.01.009_b0150","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0140-6736(22)01434-9","article-title":"The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy \u2013 Authors\u2019 reply","volume":"400","author":"Pollack","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2024.01.009_b0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.20.02438","article-title":"Prostate radiotherapy with adjuvant androgen deprivation therapy (ADT) improves metastasis-free survival compared to neoadjuvant ADT: an individual patient meta-analysis","volume":"39","author":"Spratt","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168324002192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168324002192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:11:25Z","timestamp":1762978285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168324002192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"alternative-id":["S2666168324002192"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2024.01.009","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2024.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}